Anonymous ID: 3832a1 Oct. 7, 2021, 7:42 p.m. No.100583   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>0597

Regarding the odd spectrum of toxicity - adverse events observed with the spike genetic vaccines compared to other vaccines, and what might be driving these effects. Just a few observations to consider.

 

https://mobile.twitter.com/RWMaloneMD/status/1446147739218219014

 

1) for J&J and Sanofi/Oxford. Adenovirus vector gene delivery tech is not without its own adverse event issues. Remember that high doses of adenovirus vectored gene therapy is what killed Jessee Gelsinger by a U Penn physician group.

 

2) there is a clear overlap in disease associated with SARS-CoV-2, the AdV spike vaccines, and the mRNA vaccines. What do they all have in common? Spike. So applying occams razor, Spike protein is the likely culprit

 

3) for the mRNA vaccines, there are at least two novel chemicals not previously widely used in humans

 

3a. First novel chemical is the tertiary amine cationic lipid that (in the case of Pfizer) notoriously disproportionally concentrates in bone marrow and ovaries

 

3b. Second novel chemical is the pseudouridine, which is the basis of the Kariko and Weissman (U Penn) patent and invention. This has never been widely deployed in humans. It is actually not necessary, as demonstrated by the CureVac SARS-CoV-2 vax product.

 

further regarding 3b. This is a modest improvement on the core tech platform which I developed. This is why they were not awarded a Nobel despite all of the media push. I know senior people at the Karolinska. The significance of this discovery was evaluated and found wanting.

 

in contrast, the switch from a quaternary amine to a tertiary amine by the Peter Cullis group was, in fact, critical tech for the major enabling improvement. Which is why all three mRNA companies use this tech.

 

This is from: Inventor of mRNA vaccines and RNA as a drug.

When the inventor says don't take itโ€ฆ

 

We're Not Gonna Take It.